Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

Organisation › Details

FDA (US Food and Drug Administration)

http://www.fda.gov

	Group	United States (govt)
	Industry	pharmaceutical

	Street	10903 New Hampshire Avenue
	City	20993-002 Silver Spring, MD
	Tel	+1-301-575-0156
		Address record changed: 2011-08-20

Basic data	Employees	H: 10,001 to 50,00 (2006-08-01)


		Record changed: 2019-10-26

More documents for United States (govt)

[1] Roche. (11/25/19). "Press Release: FDA Grants Priority Review to Roche’s Risdiplam for Spinal Muscular Atrophy". Basel....
[2] Adaptimmune Ltd.. (10/5/19). "Press Release: United States Orphan Drug Designation for Treatment of Soft Tissue Sarcomas Granted to SPEAR T-cells Targeting MAGE-A4". Philadeliphia, PA & Oxfordshire....
[3] Immunexpress, Inc.. (10/3/19). "Press Release: Immunexpress Announces Closing of Private Funding Round". Seattle, WA....
[4] Roche. (9/20/19). "Press Release: FDA Approves cobas Babesia, Roche’s First Whole Blood Test for Donor Screening". Basel....
[5] Roche. (9/18/19). "Press Release: FDA Grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis". Basel....
[6] Novartis AG. (9/6/19). "Press Release: Novartis Investigational Lung Cancer Therapy Capmatinib (INC280) Granted FDA Breakthrough Therapy Designation for Patients with MET-mutated Advanced Non-small Cell Lung Cancer". Basel....
[7] Inotrem S.A.. (9/3/19). "Press Release: Inotrem Announces Fast Track Designation Granted by U.S. FDA to Nangibotide Development Program for the Treatment of Septic Shock". Paris....
[8] Amoéba S.A.. (8/19/19). "Press Release: Amoéba Informs that the EPA Cannot Grant the Registrations for the Use of Its Active Substance Willaertia magna C2c Maky in Cooling Towers". Lyon....
[9] Nabriva Therapeutics plc. (8/19/19). "Press Release: Nabriva Therapeutics Receives U.S. FDA Approval of Xenleta (lefamulin) to Treat Community-Acquired Bacteria Pneumonia (CABP)". Dublin....
[10] Nabriva Therapeutics plc. (8/16/19). "Press Release: Nabriva Therapeutics Provides Update on the Planned Resubmission of the New Drug Application for Intravenous Contepo (fosfomycin) for Injection". Dublin....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]